Director, Thyroid Oncology Program
Endocrinology
Dr. Kenneth B. Ain, MD
|
|
Give Review
Kenneth is an expert in the field of Endocrinology. He researched medicine at Warren Alpert Medical School of Brown University. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "America's Top Doctors for Cancer". Kenneth is a published doctor and has 64 publications published. The lastest was: 'Anaplastic thyroid carcinoma: a therapeutic challenge.' He is registered with Medicare and accepts Medicare payments.
Publications
- Reversible Cognitive, Motor and Driving Impairments in Severe Hypothyroidism.
- Quality of life impact of external beam radiotherapy for advanced Thyroid carcinoma.
- Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary Thyroid carcinoma.
- Recurrence after treatment of micropapillary Thyroid cancer.
- Phase II trial of thalidomide for therapy of radioiodine-unresponsive and rapidly progressive Thyroid carcinomas.
- Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human Thyroid adenoma cell line, KAK-1, suggesting tran...
- Outcomes of patients with differentiated Thyroid carcinoma following initial therapy.
- Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic Thyroid carcinoma cells in vitro.
- Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic Thyroid carcinoma cell growth in vitro.
- Thyroglobulin: a specific serum marker for the management of Thyroid carcinoma.
- Pathobiology of antineoplastic therapy in undifferentiated Thyroid cancer.
- Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in Thyroid papillary carcinomas: a potential role in tumor metastasis.
- High prevalence of BRAF gene mutation in papillary Thyroid carcinomas and Thyroid tumor cell lines.
- Expression of hypothalamic-pituitary-Thyroid axis related genes in the human skin.
- Combretastatin A4 phosphate has primary antineoplastic activity against human anaplastic Thyroid carcinoma cell lines and xenograft tumors.
- Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint Dysfunction without mutations in BUB1 and BUBR1.
- Papillary endothelial hyperplasia in the Thyroid following fine-needle aspiration.
- Generalized resistance to Thyroid hormone associated with a mutation in the ligand-binding domain of the human Thyroid hormone receptor beta.
- Iodine-131 therapy for Thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.
- Quantitative and qualitative differences in growth, invasion and lung colonization of an anaplastic and a papillary human Thyroid cancer cell line in vitro and in vivo.
- Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular Thyroid carcinoma.
- Is familial non-medullary Thyroid carcinoma more aggressive than sporadic Thyroid cancer? A multicenter series.
- KAT45, a noradrenergic human pheochromocytoma cell line producing corticotropin-releasing hormone.
- Radioiodine therapy in patients with stage I differentiated Thyroid cancer.
- Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in Thyroid cancer cells.
- Treatment of anaplastic Thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Tr...
- American Thyroid Association guidelines for detection of thyroid Dysfunction.
- Polyamine synthesis and transport inhibition in a human anaplastic Thyroid carcinoma cell line in vitro and as xenograft tumors.
- TRAIL death pathway expression and induction in Thyroid follicular cells.
- Restoration of iodide uptake in dedifferentiated Thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
- Alzheimer's amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of v...
- Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated Thyroid carcinoma.
- Anaplastic Thyroid carcinoma: a therapeutic challenge.
- Thyrotropin suppression and Disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
- Anaplastic Thyroid carcinoma: behavior, biology, and therapeutic approaches.
- Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group.
- A unique interaction between polyamine and multidrug resistance (P-glycoprotein) transporters in cultured Chinese hamster ovary cells transfected with mouse mdr-1 gene.
- Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic Thyroid cancer cells.
- Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human Thyroid carcinoma.
- Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human Thyroid cell line, KAT-50.
- Assessment of fine-needle aspiration sampling technique in Thyroid nodules.
- Antineoplastic activity of taxol against human anaplastic Thyroid carcinoma cell lines in vitro and in vivo.
- Medullary Thyroid carcinoma imaged by Tc-99m MIBI SPECT and Tl-201 chloride/Tc-99m pertechnetate subtraction SPECT.
- Papillary Thyroid carcinoma. Etiology, assessment, and therapy.
- Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.
- Low-iodine tube-feeding diet for iodine-131 scanning and therapy.
- False-positive I-131 uptake at a tracheostomy site. Discernment with Tl-201 imaging.
- Systemic embolism in thyrotoxicosis without cardiac arrhythmia.
- Somatostatin analogs affect proliferation of human Thyroid carcinoma cell lines in vitro.
- Brain Metabolism in hypothyroidism studied with 31P magnetic-resonance spectroscopy.
- Patterns of automotive safety restraint use in rhode island: impact of the child passenger restraint law.
- Relationship of oligosaccharide modification to the cause of serum thyroxine-binding globulin excess.
- Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration.
- Effect of estrogen on the synthesis and secretion of thyroxine-binding globulin by a human hepatoma cell line, Hep G2.
- Serum thyrotropin and prolactin in the syndrome of generalized resistance to Thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term tri...
- Thyroid cancer: a lethal endocrine neoplasm.
- Pseudomalabsorption of levothyroxine.
- Unusual Types of thyroid cancer.
- Management of undifferentiated Thyroid cancer.
- Butyrate alters the expression and activity of cell cycle components in anaplastic Thyroid carcinoma cells.
- Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity.
- Somatostatin receptor subType expression in human thyroid and thyroid carcinoma cell lines.
- Effects of restricting levothyroxine dosage strength availability.
Schools
Brown University Alpert Medical School
Hahnemann University
National Institutes Of Health Clinical Center
University of Chicago
Conditions Treated
- Calcium Metabolism Disorders
- Diabetes Type 1
- Diabetes Type 2
- Goiter
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Ind Direct Access KY
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- Priority Health
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
Education
-
National Institutes of Health Clinical Center -
University of Chicago -
Drexel University - Hahnemann University Hospital -
Warren Alpert Medical School of Brown University
Hospital
-
University of Kentucky Albert B. Chandler Hospital
Drug Facts
| NPI NUMBER | 1396857173 | |
| NPPES Provider LastName | AIN | |
| NPPES Provider FirstName | KENNETH | |
| NPPES Provider ZIPCode | 405360001 | |
| NPPES Provider State | KY | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 606.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396857173 |
| Last Name Of The Provider | AIN |
| First Name Of The Provider | KENNETH |
| View All |
Similar Doctors
|
|
Dr. Kristen R. Stakelin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wendell R. Miers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lyle C. Myers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James A. Flueck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna V. Marino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vinay Maudar, MD
This Doctor is OpenDoctor Recommended.
|